Your browser doesn't support javascript.
loading
Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor.
Helman, Elena; Nguyen, Minh; Karlovich, Chris A; Despain, Darrin; Choquette, A Karin; Spira, Alexander I; Yu, Helena A; Camidge, D Ross; Harding, Thomas C; Lanman, Richard B; Simmons, Andrew D.
Affiliation
  • Helman E; Guardant Health Inc, Redwood City, CA. Electronic address: ehelman@guardanthealth.com.
  • Nguyen M; Clovis Oncology Inc, Boulder, CO.
  • Karlovich CA; Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Despain D; Clovis Oncology Inc, Boulder, CO.
  • Choquette AK; Virginia Cancer Specialists Research Institute, Fairfax, VA.
  • Spira AI; Virginia Cancer Specialists Research Institute, Fairfax, VA.
  • Yu HA; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Camidge DR; University of Colorado, Aurora, CO.
  • Harding TC; Clovis Oncology Inc, Boulder, CO.
  • Lanman RB; Guardant Health Inc, Redwood City, CA.
  • Simmons AD; Clovis Oncology Inc, Boulder, CO.
Clin Lung Cancer ; 19(6): 518-530.e7, 2018 11.
Article in En | MEDLINE | ID: mdl-30279111
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrimidines / Acrylamides / Carcinoma, Non-Small-Cell Lung / Cell-Free Nucleic Acids / Lung Neoplasms / Antinematodal Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrimidines / Acrylamides / Carcinoma, Non-Small-Cell Lung / Cell-Free Nucleic Acids / Lung Neoplasms / Antinematodal Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2018 Type: Article